Related Experiment Video

Updated: Apr 22, 2026

Studying Chronic Exposure of Mice to Ultraviolet B Radiation
03:20

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Published on: August 19, 2025

1.9K

Dermatological approach to vemurafenib skin toxicity: a single centre experience

Paolo Fava1, Elena Marra, Chiara Astrua

  • 1Department of Medical Science, University of Turin, Turin, Italy - paola.savoia@unito.it.

Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|October 10, 2014
PubMed
Abstract

Insights

Vemurafenib, a BRAF inhibitor for advanced melanoma, frequently causes skin reactions like rash and warts. Most side effects are manageable, but sun protection is crucial to mitigate photosensitivity and maintain quality of life.

Area of Science:

  • Oncology
  • Dermatology
  • Pharmacology

Background:

  • Targeted therapies, including RAF inhibitors, are transforming advanced melanoma treatment.
  • Vemurafenib is a standard therapy for metastatic BRAF-mutated melanomas.
  • Cutaneous reactions are common adverse effects of vemurafenib, impacting patient quality of life.

Purpose of the Study:

  • To offer practical management strategies for vemurafenib-induced cutaneous reactions.
  • To analyze the incidence and types of skin side effects in patients receiving vemurafenib.

Main Methods:

  • A cohort of 39 patients with BRAF-mutated metastatic melanoma was treated with vemurafenib (960 mg twice daily).
  • Patient demographics and treatment duration were recorded.
  • Cutaneous toxicities were systematically documented.

Main Results:

  • 74.4% of patients developed cutaneous toxicities after a median of 7 months.
  • Maculo-papular rash (56%) and warts (46%) were the most frequent reactions.
  • Other toxicities included keratinization alterations (25.6%), photosensitivity (15%), and keratoacanthomas (6 patients).

Conclusions:

  • Vemurafenib-related skin involvement is common but generally manageable and self-limiting.
  • Sun protection is essential for vemurafenib-treated patients to minimize photosensitivity.
  • Early implementation of sun protection strategies can improve quality of life during BRAF inhibitor therapy.

More Related Videos

The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression11:02

The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression

Published on: August 3, 2011

51.2K
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA

Published on: December 19, 2019

14.4K

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.2K
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.3K
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
7.8K
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
200
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.1K
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
219